GSK’s Jemperli shows promise in treating endometrial cancer
HQ Team October 30, 2023: GSK plc has announced significant findings from a phase III trial trial for Jemperli (dostarlimab), a potential treatment for
HQ Team October 28, 2023: A recent study conducted by a team of researchers from Denmark, the Netherlands, and the United Kingdom challenges
The World Health Organisation says that each year there are an estimated 374 million new infections with 1 of 4 curable STIs: chlamydia,
HQ Team October 26, 2023: While athlete’s foot and yeast infections are well-known, a new threat is emerging from invasive fungal infections, which
HQ Team October 26, 2023: Researchers from the University of Cambridge have devised a new approach to enhance the diagnosis of bipolar disorder.